From a subtype standpoint, classical GBM is associated with 95% EGFR amplification, whereas mesenchymal, neural, and proneural GBMs have lower rates of EGFR amplification of 29, 67, and 17%, respectively. The gene discussed is EGFR; the disease is glioblastoma.